BREAKTHROUGHS AND PROFESSIONAL UPDATES FOR PHYSICIANS FROM NORTHWESTERN MEDICINE

Breakthroughs for Physicians provides timely updates on the clinical and scientific advances made by Northwestern Medicine physicians and Northwestern University Feinberg School of Medicine faculty members. Anchored by Northwestern Memorial Hospital and Northwestern University Feinberg School of Medicine in downtown Chicago, Northwestern Medicine is achieving breakthroughs through innovative research and leading-edge clinical trials while delivering world-class patient care.
Northwestern Memorial Hospital Recognized Among the Top 10 Hospitals by U.S. News & World Report Learn more about Northwestern Medicine.

uPDATES FROM nORTHWESTERN mEDICINE


Join Lee Lindquist, MD, MPH monthly to discuss current topics and innovations with experts in the field of Geriatrics. Register now for the upcoming live, virtual event.​
The vision of Northwestern Medicine Obstetrics and Gynecology is to serve as a global leader in obstetrics, gynecology, women’s health and healthcare delivery through innovations in person-centered care, research and education. This report is a summary of our accomplishments at Northwestern Memorial Hospital and Northwestern University Feinberg School of Medicine over the last fiscal year, September 2021 to August 2022.
Hiten D. Patel, MD, assistant professor of Urology at Northwestern Medicine, discusses promising novel diagnostic approaches for small renal masses and treatment options for localized renal masses suspicious for cancer. These approaches and treatments include active surveillance, thermal ablation, radical or partial nephrectomy, and tumor enucleation.
Featuring: Igor Koralnik, MD, Eric M. Liotta, MD, MS, and Edith L. Graham, MD
Three experts from Northwestern Medicine Neurology have been investigating the pathogenic mechanisms of acute and long-term COVID-19, as they may inform clinical evaluation and management. They discuss their guideline "Therapeutic Approaches to the Neurologic Manifestations of COVID-19," published in Neurotherapeutics in July 2022.
​Featuring: ​Grazia Aleppo, MD
The Diabetes Tune-up Pathway is a population-health team-based approach designed to support patient self-management and to improve glycemic control for patients with high-risk diabetes. In this video, Dr. Aleppo explains how the Diabetes Tune-Up Pathway Program helps patients reach A1C levels of 7% of lower.
​William Gradishar, MD, FASCO, FACP, chief of Hematology and Oncology at Northwestern University Feinberg School of Medicine and Deputy Director of the Clinical Network of the Lurie Cancer Center, received the 2022 Rodger Winn Award from the National Comprehensive Cancer Network (NCCN) for his expertise and commitment to excellence in developing the NCCN Clinical Practice Guidelines.
Chicago philanthropist Neil G. Bluhm and the Bluhm Family Charitable Foundation announced a $45 million gift to establish the Northwestern Medicine Bluhm Heart Hospital at Northwestern Memorial Hospital. The gift expands cardiac care capacity and addresses health equity by providing greater access to Northwestern Medicine’s world-class cardiovascular care.​

Continuing medical education (CME)

Join leaders in urology, medical oncology, pathology and radiology for a monthly didactic lecture series on critical topics and advances in genitourinary oncology. Lectures will take place via Microsoft Teams on the first and third Thursday of the month at 5:30pm CT.
Through April 6, 2025
The Breakthroughs podcast is a series of in-depth conversations with Northwestern Medicine faculty about their leading-edge research. Each episode offers a first-person narrative of new discoveries and findings that may be unknown to the medical community. The podcast format assists in translating complicated medical research on an array of medical topics to a wide physician audience.
For a full list of CME opportunities, visit Continuing Medical Education at Feinberg School of Medicine. 

Clinical Trials

A Randomized Phase 2 Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Subjects Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) and FGFR Mutations or Fusions

Principal Investigator: Joshua J. Meeks, MD, PhD

Improving the Pelvic Health of Women and Girls Through the Use of a Digital Coaching Platform

Principal Investigator: Kimberly Sue Kenton, MD

MISCEND

Principal Investigator: Charles J. Davidson, MD
​Sub-Investigator: S. Christopher Malaisrie, MD

Healthy Control Esophageal Registry and Biorepository

​Principal Investigator: Dustin A. Carlson, MD, MS
To view all clinical trials, visit Clinical Trials at Feinberg School of Medicine.